Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease

被引：0
|
作者：
Nils-Olov Stålhammar
Jonas Carlsson
Robert Peacock
Stefan Müller-Lissner
Marc-André Bigard
Gabriele B. Porro
Julio Ponce
James Hosie
Mairi Scott
Donald G. Weir
Claire Fulton
Keith Gillon
Karna D. Bardhan
机构：
[1] AstraZeneca R & D Mölndal,Health Economics
[2] Astra Hässle AB,Biostatistics
[3] Astra Clinical Research Unit,Department of Medicine
[4] Krankenhaus Weibensee,Service d’hepato
[5] Hôpital Brabois,gastro
[6] Ospedale L. Sacco,enterologie
[7] C. S. ’La Fe’,Divisione di Gastroenterologia ed Endoscopia Digestiva
[8] Great Western Medical Centre,Servicio de Digestivo
[9] Medical Centre,General Practice
[10] St James’ Hospital,General Practice
[11] Astra Hässle AB,Department of Medicine and Gastroenterology
[12] Rotherham District General Hospital,Clinical Research Management
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Adis International Limited; Omeprazole; Ranitidine; Reflux Oesophagitis; Direct Medical Cost;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: This 1-year study compared the cost effectiveness of omeprazole and ranitidine when used as initial therapy in an intermittent treatment strategy for the management of patients with symptomatic gastro-oesophageal reflux disease with or without erosive oesophagitis.
引用
收藏
页码：483 / 497
页数：14
相关论文
共 50 条
  • [1] Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease
    Stålhammar, NO
    Carlsson, J
    Peacock, R
    Müller-Lissner, S
    Bigard, MA
    Porro, GB
    Ponce, J
    Hosie, J
    Scott, M
    Weir, DG
    Fulton, C
    Gillon, K
    Bardhan, KD
    PHARMACOECONOMICS, 1999, 16 (05) : 483 - 497
  • [2] Symptomatic gastro-oesophageal reflux disease:: double blind controlled study of intermittent treatment with omeprazole or ranitidine
    Bardhan, KD
    Müller-Lissner, S
    Bigard, MA
    Porro, GB
    Ponce, J
    Hosie, J
    Scott, M
    Weir, DG
    Gillon, KRW
    Peacock, RA
    Fulton, C
    BRITISH MEDICAL JOURNAL, 1999, 318 (7182): : 502 - +
  • [3] Cost effectiveness of treatment for gastro-oesophageal reflux disease
    Crawley, JA
    GUT, 1998, 43 (05) : 729 - 729
  • [4] Cost effectiveness of treatment for gastro-oesophageal reflux
    Laheij, RJF
    Jansen, JBMJ
    Severens, JL
    Verbeek, ALM
    GUT, 1998, 43 (05) : 728 - 729
  • [5] Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease
    Jaspersen, D
    Schwacha, H
    Schorr, W
    Brennenstuhl, M
    Raschka, C
    Hammar, CH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (10) : 900 - 902
  • [6] Cost effectiveness of laparoscopic surgery for gastro-oesophageal reflux disease
    Ahmed, E
    Decadt, B
    Gray, M
    BRITISH JOURNAL OF SURGERY, 1998, 85 : 85 - 85
  • [7] Omeprazole for asthma with gastro-oesophageal reflux
    Field, SK
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (06) : 1495 - 1495
  • [8] One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease
    Johnsson, F
    Weywadt, L
    Solhaug, JH
    Hernqvist, H
    Bengtsson, L
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (01) : 15 - 20
  • [9] Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease?
    Hendel, J
    Hendel, L
    Aggestrup, S
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 (06) : 693 - 697
  • [10] Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease
    Bate, CM
    Riley, SA
    Chapman, RWG
    Durnin, AT
    Taylor, MD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (01) : 59 - 66
12345